Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Pfizer Animal Health assets purchased by Lilly

Pfizer Animal Health assets purchased by Lilly

9th March 2010

Pfizer Animal Health has agreed a deal which will see it transfer a number of its assets to fellow healthcare group Lilly.

The veterinary pharmaceutical company is selling the European rights to several vaccines, parasiticides and feed additives to Lilly’s animal health division Elanco, as part of the terms of its recent acquisition of Wyeth.

As a result, Lilly will also take control of one of Pfizer Animal Health’s manufacturing facilities in Sligo, Ireland, with all staff set to be offered positions at Lilly.

In return, Pfizer will receive an undisclosed upfront payment, with the closing of this transaction still subject to approval from the appropriate regulatory bodies.

Jeff Simmons, president of Elanco, welcomed the purchase, saying that Pfizer’s product portfolio and facility represent “a natural fit for Elanco and positions us well for sustained growth”.

Last week, Pfizer Animal Health licensed a vaccine enhancement and delivery developed by Immunovaccine in order to produce a new livestock treatment.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.